Dr. Matthias Guckenberger

Dr. Matthias Guckenberger is an experienced Radiation Oncologist with 16 years of practice, specializing in the treatment of lung and prostate cancers, as well as oligometastases. He practices at his clinic in Zürich, where he provides cutting-edge radiation therapies for various malignancies, including advanced techniques such as stereotactic body radiation therapy (SBRT) and intensity-modulated radiation therapy (IMRT). His comprehensive approach to treating cancer aims at improving survival rates while minimizing side effects, focusing on the latest advancements in therapeutic radiation.

Dr. Guckenberger is actively involved in clinical and translational research, particularly in the areas of lung cancer, prostate cancer, and the treatment of oligometastases. He has contributed to numerous research projects that aim to refine radiation techniques, improve treatment efficacy, and enhance patient outcomes. His work has been published in several leading oncology journals, and he regularly contributes to international cancer conferences.

• Best Radiation Oncologist of the Year, Swiss Medical Association (2017)

• Excellence in Cancer Treatment, European Society for Radiotherapy and Oncology (ESTRO) (2018)

• Leading Expert in Oligometastatic Treatment, International Society for Radiation Oncology (2020)

Dr. Guckenberger has published multiple research papers on topics including lung cancer, prostate cancer, and novel radiation techniques for the treatment of oligometastases. His work has appeared in journals such as The Lancet Oncology, Radiotherapy and Oncology, and European Journal of Cancer. He is also a frequent reviewer for major oncology and radiation journals.